{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-22-001759","form_type":"8-K","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2022-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.418462+00:00","generated_at":"2026-06-27T07:22:13.630054+00:00","sec_items":["4.01","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zivo Bioscience appoints BDO as auditor and finalizes CEO John Payne's employment contract","bullets":["Appointed BDO USA, LLP as independent auditor effective February 10, 2022, replacing resigned auditor Wolinetz, Lafazan & Company.","CEO John Payne's contract provides $400k annual salary, bonus up to 125% of salary, and annual equity awards valued at $400k.","ZIVO 2021 Plan reserves 1,000,000 shares with automatic annual increase of 5% of outstanding shares through 2031."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-22-001759","json":"https://secwatch.observer/filing/0001654954-22-001759.json","markdown":"https://secwatch.observer/filing/0001654954-22-001759.md","text":"https://secwatch.observer/filing/0001654954-22-001759.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422001759/0001654954-22-001759-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422001759/zivo_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:22:13.630054+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}